Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
2 studies found for:    9673301 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease;   Diabetes Mellitus, Type 2
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Aspirin
2 Completed Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus Type 2;   Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: simvastatin;   Drug: Ezetimibe 10/Simvastatin 20
To Top

† Indicates status has not been verified in more than two years